These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24702504)

  • 1. Investigational drugs in Alzheimer's disease: current progress.
    Berk C; Paul G; Sabbagh M
    Expert Opin Investig Drugs; 2014 Jun; 23(6):837-46. PubMed ID: 24702504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical to phase II amyloid beta (A
    Parsons CG; Rammes G
    Expert Opin Investig Drugs; 2017 May; 26(5):579-592. PubMed ID: 28362514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease.
    Anand K; Sabbagh M
    Expert Opin Investig Drugs; 2015; 24(10):1355-60. PubMed ID: 26289787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solanezumab for Alzheimer's disease.
    Samadi H; Sultzer D
    Expert Opin Biol Ther; 2011 Jun; 11(6):787-98. PubMed ID: 21504387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015.
    Mehta D; Jackson R; Paul G; Shi J; Sabbagh M
    Expert Opin Investig Drugs; 2017 Jun; 26(6):735-739. PubMed ID: 28460541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel disease-modifying therapies for Alzheimer's disease.
    Jiang T; Yu JT; Tan L
    J Alzheimers Dis; 2012; 31(3):475-92. PubMed ID: 22669013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biogen's aducanumab raises hope that Alzheimer's can be treated at its source.
    Patel KR
    Manag Care; 2015 Jun; 24(6):19. PubMed ID: 26182718
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease.
    Wicke K; Haupt A; Bespalov A
    Expert Opin Investig Drugs; 2015; 24(12):1515-28. PubMed ID: 26548316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody drugs for Alzheimer's show glimmers of promise.
    Reardon S
    Nature; 2015 Jul; 523(7562):509-10. PubMed ID: 26223602
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
    Li Y; Liu Y; Wang Z; Jiang Y
    Expert Opin Biol Ther; 2013 Nov; 13(11):1515-22. PubMed ID: 24053611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Amyloid as a molecular therapeutic target in Alzheimer's disease.
    Adlard PA; James SA; Bush AI; Masters CL
    Drugs Today (Barc); 2009 Apr; 45(4):293-304. PubMed ID: 19499094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-amyloid-β protein agents for the treatment of Alzheimer's disease: an update on emerging drugs.
    Lozupone M; Solfrizzi V; D'Urso F; Di Gioia I; Sardone R; Dibello V; Stallone R; Liguori A; Ciritella C; Daniele A; Bellomo A; Seripa D; Panza F
    Expert Opin Emerg Drugs; 2020 Sep; 25(3):319-335. PubMed ID: 32772738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and emerging treatments for Alzheimer's disease.
    Corbett A; Ballard C
    Expert Opin Emerg Drugs; 2012 Jun; 17(2):147-56. PubMed ID: 22439621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed results for disease-modification strategies for Alzheimer's disease.
    Opar A
    Nat Rev Drug Discov; 2008 Sep; 7(9):717-8. PubMed ID: 19172684
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies.
    Rygiel K
    Indian J Pharmacol; 2016; 48(6):629-636. PubMed ID: 28066098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-based therapy in Alzheimer's disease.
    Pul R; Dodel R; Stangel M
    Expert Opin Biol Ther; 2011 Mar; 11(3):343-57. PubMed ID: 21261567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genentech's Alzheimer's antibody trial to study disease prevention.
    Garber K
    Nat Biotechnol; 2012 Aug; 30(8):731-2. PubMed ID: 22871696
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.
    Prakash A; Kalra J; Mani V; Ramasamy K; Majeed AB
    Expert Rev Neurother; 2015 Jan; 15(1):53-71. PubMed ID: 25495260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of gantenerumab and its potential in the treatment of Alzheimer's disease.
    Novakovic D; Feligioni M; Scaccianoce S; Caruso A; Piccinin S; Schepisi C; Errico F; Mercuri NB; Nicoletti F; Nisticò R
    Drug Des Devel Ther; 2013; 7():1359-64. PubMed ID: 24255592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.